About the Company
A continuous glucose monitor (CGM) is a device for monitoring blood glucose continuously instead of monitoring periodically by drawing a drop of blood from a finger. This is known as continuous glucose monitoring. CGMs are used by people who treat their diabetes with insulin, for example people with type 1 diabetes, type 2 diabetes, or other types of diabetes, such as gestational diabetes. A continuous glucose monitor has three parts: a small electrode that is placed under the skin a transmitter that sends readings from the electrode to a receiver at regular intervals (every 1 to 15 minutes) a separate receiver that shows the glucose level on a display. Approved CGMs use an enzymatic technology which reacts with glucose molecules in the body's interstitial fluid to generate an electric current that is proportional to glucose concentration. Data about glucose concentration is then relayed from a transmitter attached to the sensor, to a receiver that displays the data to the user. Some CGM devices must be calibrated periodically with traditional blood glucose measurements, but others do not require calibration by the user.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Glucose Health, Inc.
Glucose Health, Inc. (OTC: GLUC) Highlights U.S. Department of Health ...
Glucose Health, Inc.’s early-mover leadership in the fiber-based nutrition sector is a key theme of the advertising campaign, aligning with the U.S. Department of Health and Human Services (HHS ...
U.S. Department of Health and Human Services Designates Four ... - ABC27
Glucose Health, Inc.’s flagship diabetic nutrition brand GlucoDown® is a dietary fiber-infused nutrition drink scientifically formulated to support balanced glucose levels particularly after meals.
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX ...
Trividia Health, Inc., announced today that its TRUE METRIX® Self-Monitoring Blood Glucose Systems are preferred on all Managed Medicaid Plans and Fee-for-Service Medicaid in Pennsylvania ...
Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022
BENTONVILLE, AR, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (GLUC) ("Company") is pleased to highlight selected financial information from its third Quarterly Report of Fiscal 2022 ...
Similar Companies
Loading the latest forecasts...